Followers | 63 |
Posts | 8502 |
Boards Moderated | 0 |
Alias Born | 01/10/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 10, 2020 12:23:07 PM
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, announced today that it has delivered the 100,000th whole human genome sequence dataset to the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP). Although Personalis has been contracted by the VA MVP since 2012, the program has accelerated and over 50,000 of these genomes have been delivered in 2020.
"The VA MVP is the largest whole genome sequencing project in the United States and this is a significant milestone for both the program and for Personalis," said John West, Chief Executive Officer. "Population-scale sequencing projects of this nature represent a cornerstone in our effort to accelerate the advancement of precision medicine across a wide range of disease areas. With our sizable investments in the technology and infrastructure, necessary to win and execute these projects, Personalis sees population genomics and health as key priorities for our company. We congratulate the VA MVP for their visionary leadership and note that VA scientists now list over 50 peer reviewed publications from the Program."
https://finance.yahoo.com/news/personalis-announces-delivery-100-000th-210700535.html
“Believing in negative thoughts is the single greatest obstruction to success.”
Charles F. Glassman
Statements made are only my opinion. Do your own DD in order to make your own investment decisions.
Recent PSNL News
- Personalis to Announce Second Quarter 2024 Financial Results • Business Wire • 07/24/2024 08:01:00 PM
- Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing • GlobeNewswire Inc. • 07/11/2024 01:00:00 PM
- Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference • Business Wire • 06/18/2024 08:01:00 PM
- Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call • Business Wire • 06/13/2024 12:00:00 PM
- ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring • Business Wire • 06/04/2024 08:05:00 PM
- Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus • Business Wire • 05/31/2024 01:05:00 PM
- Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024 • Business Wire • 05/22/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 01:14:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 01:11:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:12:17 PM
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/17/2024 08:05:00 PM
- Personalis Reports First Quarter 2024 Financial Results • Business Wire • 05/08/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:00:17 PM
- Personalis to Announce First Quarter 2024 Financial Results • Business Wire • 04/24/2024 08:01:00 PM
- Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 03/28/2024 08:01:00 PM
- Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting • Business Wire • 03/28/2024 01:00:00 PM
- Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring • Business Wire • 03/26/2024 01:00:00 PM
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/19/2024 08:43:00 PM
- Personalis Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/28/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:00:11 PM
- Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/14/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:30:33 PM
- Personalis to Participate at Upcoming Investor Conferences • Business Wire • 01/31/2024 09:01:00 PM
- Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology • Business Wire • 01/30/2024 02:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/29/2024 09:00:59 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM